Dalian, China

Zhengxian Liu



 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:

goldMedal4 out of 832,912 
Other
 patents

Years Active: 2019-2021

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Zhengxian Liu: Innovator in Antiviral Composition

Introduction

Zhengxian Liu is a notable inventor based in Dalian, China. He has made significant contributions to the field of antiviral medications, holding a total of 4 patents. His work focuses on developing compositions that effectively alleviate and treat viral diseases.

Latest Patents

Liu's latest patents include the application of a phillyrin/phillygeninin composition in preparing a medicine or health care product for alleviating or treating viral diseases. This invention discloses a composition that has shown significant treatment effects on various viral infections, including influenza and pneumonia. The composition is characterized by its quick action and minimal toxic side effects, making it a promising antiviral drug suitable for industrial production. Another notable patent involves a novel phillygenin glucuronic acid derivative, which is also aimed at treating antiviral diseases.

Career Highlights

Throughout his career, Zhengxian Liu has worked with various companies, contributing to advancements in pharmaceutical compositions. His innovative approach has led to the development of effective health products that are easy to promote and manufacture.

Collaborations

Liu has collaborated with notable individuals in his field, including Li Fu and Kaiqian Wang. These partnerships have enhanced his research and development efforts, leading to impactful inventions.

Conclusion

Zhengxian Liu's contributions to antiviral compositions highlight his role as a significant inventor in the pharmaceutical industry. His innovative work continues to pave the way for effective treatments against viral diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…